Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

BACKGROUND: Healthcare-associated infections involving Gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered outcomes and poses daily therapeutic challenges in most of intensive care units worldwide. Over the recent years, four...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, François, Hraiech, Sami, Kernéis, Solen, Veluppillai, Nathanaël, Pajot, Olivier, Poissy, Julien, Roux, Damien, Zahar, Jean-Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354316/
https://www.ncbi.nlm.nih.gov/pubmed/37462830
http://dx.doi.org/10.1186/s13613-023-01153-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354316/
https://www.ncbi.nlm.nih.gov/pubmed/37462830
http://dx.doi.org/10.1186/s13613-023-01153-6

Ejemplares similares